
![]()
Pharmaceutical product overview
| Indication | Product | Full year 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Alzheimer's disease | 815 |
29% |
|
| Parkinson's disease | 502 |
20% |
|
| Epilepsy | 451 |
9% |
|
| Attention deficit disorder | 440 |
17% |
|
| Epilepsy | 332 |
-52% |
|
| Indication | Product | Full year 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Hypertension | 5740 |
15% |
|
| Cholesterol reduction | 645 |
-3% |
|
| Hypertension | 406 |
294% |
|
| Hypertension | 386 |
-48% |
|
| Indication | Product | Full year 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Asthma | 387 |
7% |
|
| Cystic Fibrosis | 295 |
8% |
|
| Indication | Product | Full year 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Transplantation | 956 |
1% |
|
| Transplantation | 290 |
50% |
|
| Indication | Product | Full year 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Chronic myeloid leukemia | 3670 |
20% |
|
| Cancer complications | 1382 |
7% |
|
| Breast cancer | 1129 |
20% |
|
| Acromegaly | 1123 |
9% |
|
| Iron chelator | 531 |
49% |
|
| Indication | Product | Full year 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD | Inflammation / pain | 814 |
9% |
| Indication | Product | Full year 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Age-related macular degeneration | 886 |
125% |
|
Quarterly results
View and download the latest quarterly reports from Novartis.
Corporate publications

Download our latest financial reports.
Form 20-F
(1.1 MB)